{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Felodipine",
            "Path": "../../Felodipine-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": [],
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "IV 1.5mg (60min)"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "Oral solution"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "Oral solution MD"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "IR tablet 5mg"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "IR tablet 10mg"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "ER tablet 5mg"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "ER tablet 10mg"
            },
            {
                "SectionId": 331,
                "Project": "Felodipine",
                "Simulation": "ER tablet OD 10mg"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "ER tablet 10mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "ER tablet 5mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "ER tablet OD 10mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "ER tablet OD 2.5/5mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "IR tablet BID 10mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "IR tablet OD 10mg_test"
            },
            {
                "SectionId": 332,
                "Project": "Felodipine",
                "Simulation": "IR tablet TID 5mg_test"
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Felodipine concentration in plasma",
                "SectionId": 32,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "Intravenous administration (model building)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "IV 1.5mg (60min)",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Lundahl 1997 - 1.5mg-IV infusion - Felodipine - IV - 1.5 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, solution (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "Oral solution",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Edgar 1987 - 10mg-PO solution - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "Oral solution MD",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study I-10mg-PO solution - Felodipine - PO - 10 mg - Plasma - agg. (n=18)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "Oral solution MD",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Edgar 1987 - 10mg-PO solution - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, ER tablet (model building)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 5mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Goosen 2004 - 5mg-PO ER tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=11)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 5mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Jalava 1997 - 5mg-PO ER tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=9)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Edgar 1987 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 1996 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Gelal 2005 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Serum - agg. (n=10)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 2003 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=8)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study II-10mg-PO ER tablet-market - Felodipine - PO - 10 mg - Plasma - agg. (n=15)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Lundahl 1998 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 1995 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Aberg 1997 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=36)",
                                "Color": "#2166ac"
                            }                            
                        ]
                    },
                    {
                        "Caption": "Oral administration, IR tablet (model building)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet 5mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 1993 - 5mg-PO IR tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=9)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet 5mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Edgar 1992 - 5mg-PO IR tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=9)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet 10mg",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Edgar 1987 - 10mg-PO IR tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            }                                                                                   
                        ]
                    },
                    {
                        "Caption": "Oral administration, ER tablet (model verification)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dresser 2017 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=5)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dresser 2002 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=11)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 2000 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bailey 1998 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Lundahl 1997 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Madsen 1996 - 10mg-PO ER tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=12)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet 5mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dresser 2000 - 5mg-PO ER tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=12)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study II-10mg-PO ER tablet-trial - Felodipine - PO - 10 mg - Plasma - agg. (n=15)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "ER tablet OD 2.5/5mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dresser 2000 - 2.5mg,5mg-PO ER tablet - Felodipine - PO - 2.5, 5 mg - Plasma - agg. (n=6)",
                                "Color": "#b2182b"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, IR tablet (model verification)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet BID 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Smith 1987 - 10mg-PO IR tablet - Felodipine - PO - 10 mg - Plasma - agg. (n=8)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet BID 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study I-10mg-PO IR tablet-market - Felodipine - PO - 10 mg - Plasma - agg. (n=18)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet BID 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study I-10mg-PO IR tablet-trial - Felodipine - PO - 10 mg - Plasma - agg. (n=18)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet OD 10mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Blychert 1990 - Study II-10mg-PO ER tablet-market - Felodipine - PO - 10 mg - Plasma - agg. (n=15)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Felodipine",
                                "Simulation": "IR tablet TID 5mg_test",
                                "Output": "Organism|PeripheralVenousBlood|Felodipine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bratel 1989 - 5mg-PO IR tablet - Felodipine - PO - 5 mg - Plasma - agg. (n=11)",
                                "Color": "#b2182b"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Felodipine",
            "Name": "Felodipine",
            "Type": "Compound",
            "SectionId": 31
        },
        {
            "Project": "Felodipine",
            "Name": "Felodipine_IR tablet",
            "Type": "Formulation",
            "SectionId": 31
        },
        {
            "Project": "Felodipine",
            "Name": "Felodipine_ER tablet",
            "Type": "Formulation",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Title": "2.1 Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Id": 22,
                    "Title": "2.2 Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Id": 23,
                    "Title": "2.3 Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Id": 3,
            "Title": "3 Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Id": 31,
                    "Title": "3.1 Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Id": 32,
                    "Title": "3.2 Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Id": 33,
                    "Title": "3.3 Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "3.3.1 Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "3.3.2 Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Title": "4 Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Id": 5,
            "Title": "5 References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}